Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologics.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 12, 2017
Quantitative proteomic profiling identifies protein correlates to EGFR kinase inhibition.
Journal: Molecular cancer therapeutics
Published: March 14, 2012
Showing 1-2 of 2
Last Updated: 09/26/2026